(-)-3β-substituted ecgonine methyl esters as inhibitors for cocaine binding and dopamine uptake

Journal of Medicinal Chemistry

Volumn 41, Issue 6, 1998, Pages 864-876

  Lieske, Spencer F ^a  

^a School of Pharmacy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 METHYL 3 (BETA STYRENYL) 8 AZABICYCLO[3.2.1]OCTANE 2 CARBOXYLIC ACID METHYL ESTER; COCAINE; COCAINE DERIVATIVE; DOPAMINE; ECGONINE METHYL ESTER; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CORPUS STRIATUM; DOPAMINE UPTAKE; DRUG SYNTHESIS; MALE; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; RAT; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION;

ANIMALS; CARRIER PROTEINS; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DRUG; SOLUBILITY; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; SYNAPTOSOMES;

EID: 0032510441     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970025h     Document Type: Article

References (66)

1. Horn, A. S. The Neurobiology of Dopamine; Academic Press: New York, 1979.
2. Horn, A. S. Dopamine uptake: A review of progress in the last decade. Prog. Neurobiol. 1990, 34, 387-400.
3. Wise, R. A. Catecholamine theories of reward: A critical review. Brain Res. 1978, 152, 215-247.
4. Kuhar, M. J.; Ritz, M. C.; Boja, J. W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 1991, 14, 299-302.
5. Kuhar, M. J. Molecular pharmacology of cocaine: A dopamine hypothesis and its implications. Ciba Foundation Symposium 1992,166, 81-95.
6. Richelson, E.; Pfenning, M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake. EUT. J. Pharmacol. 1984, 104, 277-286.
7. Phillips, A. G. Brain reward circuitry: A case for separate systems. Brain Res. Bull. 1984, 12, 195-201.
8. Goeders, N. C.; Smith, J. E. Reinforcing properties of cocaine in medial prefrontal cortex: Primary action on presynaptic dopaminergic terminals. Pharmacol. Biochem. Behav. 1986,25, 191199.
9. Dewit, H.; Wise, R. A. Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide but not with the noradrenergic blockers phentolamine and phenoxybenzamine Can. J. Psychol. 1977, 31, 195-203.
10. Ritz, M. C.; Lamb, R. J.; Goldberg, S. R.; Kuhar, M. J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987, 237, 1219-1223.
11. 3H] cocaine in striatum and its relationship to the dopamine transporter. Membr. Biochem. 1988, 7, 87-106.
12. Roberts, D. C. S.; Corcoran, M. E.; Fibiger, H. C. On the role of ascending catecholaminergic systems in intravenous selfadministration of cocaine. Pharmacol. Biochem. Behav. 1977, 6, 615-620.
13. Roberts, D. C. S.; Kobb, G. F.; Klonoff, P.; Fibiger, H. C. Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 1980, 12, 781-787.
14. Roberts, D. C. S.; Kobb, G. F. Disruption of cocaine selfadministration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol. Biochem. Behav. 1982,17, 901-04.
15. Martin-Iverson, M. T.; Szostak, C.; Fibiger, H. C. 6-hydroxydopamine lesions of the medial prefrontal cortex fail to influence intravenous self-administration of cocaine. Psycopharmacology 1986, 88, 310-14.
16. Berger, P.; Gawin, F. H.; Kosten, T. R. Treatment of cocaine abuse with mazindol. Lancet 1989, No. 1, 283.
17. Calligaro, D. O.; Eldefrawi, M. E. Central and peripheral cocaine receptors. J. Pharmacol. Exp. Ther. 1987, 243, 61-68.
18. 3H] dopamine uptake is similar in both the rat striatum and nucleus accumbens. Eur. J. Pharmacol. 1989, 773, 215-17.
19. Boja, J. W.; Carrol, F. L; Rahman, M. L; Phillip, A.; Lewin, A. H.; Kuhar, M. J. New, potent cocaine analogs: Ligand binding and transport studies in rat striatum. Eur. J. Pharmacol. 1990, 184, 329-332.
20. Ritz, M. C.; Cone, E. J.; Kuhar, M. J. Cocaine inhibition of ligand binding at DA, NE, and serotonin transporters: A structureactivity relationship study. Life Sci. 1990, 46, 635-645.
21. Boja, J. W.; McNeil, R. M.; Lewin, A. H.; Abraham, P.; Carroll, F. I.; Kuhar, M. J. Selective dopamine transporter inhibition by cocaine analogs. Neuroport 1992, 3, 984-86.
22. Shimada, S.; Kitayama, S.; Lin, C.; Patel, A.; Nanthakuma, E.; Gregor, P.; Kuhar, M. J.; Uhl, G. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 1991, 254, 576-78.
23. Kitayama, S.; Shimada, S.; Xu, H.; Markham, L.; Donovan, D. M.; Uhl, G. R. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc. Natl. Acad. Sci., U.S.A. 1992, 89, 7782-7785.
24. Neve, K. A.; Cox, B. A.; Henningsen, R. A.; Spanoyannis, A.; Neve, R. Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenyl cyclase. Mol. Pharmacol. 1991, 39, 733-739.
25. Zimanyi, L; Lajtha, A.; Reith, M. E. A.;. Comparison of characteristics of dopamine uptake and mazindol binding in mouse striatum. Naunyn-Schmeideberg's Arch. Pharmacol. 1989,340, 626-632.
26. Anderson, P. H. The dopamine uptake inhibitor GBR 12909: Selectivity and molecular mechanism of action. Eur. J. Pharmacol. 1989, 166, 493-504.
27. Krueger, B. K. Kinetics and block of dopamine uptake in synaptosomes from rat caudate nucleus. J. Neurochem. 1990, 55, 260-267.
28. 3H] cocaine binding sites in caudate-putamen. J. Pharmacol. Exp. Ther. 1989, 257, 131-141.
29. Spealman, R. D.; Madras, B. K.; Berman, J. Effects of cocaine and related drugs in nonhuman prmates. II. stimulant effects on schedule-controlled behavior! J. Pharmacol. Exp. Ther. 1989, 251, 142-149.
30. Raymon, L. P.; Eldefrawi, M. E. Partial purification of cocaine receptors from rat brain, Ph.D. Thesis, University of Maryland at Baltimore, 1994.
31. Carroll, F. I.; Lewin, A. H.; Abraham, P.; Parham, K.; Boja, J. W.; Kuhar, M. J. Synthesis and ligand binding of cocaine isomers at the cocaine receptor. J. Med. Chem. 1991, 34, 883-886.
32. Lewin, A. H.; Gao, Y.; Abraham, P.; Boja, J. W.; Kuhar, M. J.; Carroll, F. I. 2β-substituted analogues of cocaine. Synthesis and inhibition of binding to the cocaine receptor. J. Med. Chem. 1992, 35, 135-140.
33. Carroll, F. L; Lewin, A. H.; Kuhar, M. J.; Boja, J. W. Cocaine receptor: A structure-activity relationship study. NIDA Research Monograph Series 1993, 134, 229-237.
34. Kozikowski, Alan P.; Roberti, Marinella; Xiang, Li; Bergmann, John S.; Callahan, Patrick M.; Cunningham, Kathryn A.; Johnson, Kenneth M. Structure-activity relationship studies of cocaine: Replacement of the C-2 ester group by vinyl argues against H-bonding and provides an esterase-resistant, highaffinity cocaine analog. J. Med. Chem. 1992, 35, 4764-4766.
35. Kozikowski, Alan P.; Xiang, Li; Tanaka, Junji; Bergmann, John S.; Johnson, Kenneth M. Use of nitrile oxide cycloaddition (NOG) chemistry in the synthesis of cocaine analogs; mazindol binding and dopamine uptake studies, Med. Chem. Res. 1991, 1, 312321.
36. Kozikowski, A. P.; Roberti, M.; Johnson, K. M.; Bergmann, J. S.; Ball, R. G. SAR of cocaine: Further exploration of structural variations at the C-2 center provides compounds of subnanomolar binding potency. Bioorg. Med. Chem. Lett. 1993, 3 (6), 1327-1332.
37. Kozikowski, A. P.; Eddine Saiah, M. K.; Johnson, K. M; Bergmann, J. S. Chemistry and biology of the 2β-alkyl-3β-phenyl analogues of cocaine: Subnanomolar affinity ligands suggest a new pharmacophore model at the C-2 position. J. Med. Chem. 1995, 38, 3086-3093.
38. Kelkar, S. V.; Izenwasser, S.; Katz, J. L.; Klein C. L.; Zhu, N.; Trudell, M. L. Synthesis, cocaine receptor affinity, and dopamine uptake inhibition of several new 2β-substituted 3β-phenyltropanes. J. Med. Chem. 1994, 37, 3875-3877.
39. Reith, M. E. A.; Meisler, B. E.; Sershen, H.; Lajtha, A. Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem. Pharmacol. 1986, 35, 11231129.
40. Madras, B. K.; Kamien, J. B.; Fahey, M. A.; Canfield, D. R.; Milius, R. A.; Saha, J. K.; Neumeyer, J. L.; Spealman, R. D. N-modified fluorophenyltropane analogs of cocaine with high affinity for cocaine receptors. Pharmacol. Biochem. Behav. 1990, 35, 949-953.
41. Stoelwinder, J.; Roberti, M.; Kozikowski, A. P.; Johnson, K M.; Bergmann, J. S. Differential binding and dopamine uptake activity of cocaine analogs modified at nitrogen. Bioorg. Med. Chem. Lett. 1994, 4 (2), 303-308.
42. Clarke, R. L.; Daum, S. J.; Gambino, A. J.; Aceto, M. D.; Pearl, J.; Levitt, M.; Cuminskey, W. R.; Bogado, E. F. Compounds affecting the central nervous system. 4. 3/î-phenyltropane-2carboxylic esters and analogs. J. Med. Chem. 1973, 16, 12601267.
43. Meltzer, P. C.; Liang, A. Y.; Browell, A. L.; Elmaleh, D. R.; Madras, B. K. Substituted 3-phenyltropane analogs of cocaine: Synthesis, inhibition of binding at cocajne recognition sites, and positron emission topography imaging. J. Med. Chem. 1993,36, 855-862.
44. Carroll, F. I.; Gao, Y.; Rahman, M. A.; Abraham, P.; Parham, K.; Lewin, A. H.; Boja, J. W., Kuhar, M. J. Synthesis, ligand binding, QSAR, and CoMFA study of 3β-(p-substituted phenyl)tropane-2β-carboxylic acid methyl esters. J. Med. Chem. 1991, 34, 2719-2725.
45. Kline, R. H., Jr.; Wright, J.; Eshleman, A.; Fox, K. M.; Eldefrawi, M. E. Synthesis of 3b-carbamoylecgonine methyl ester analogues as inhibitors of cocaine binding and dopamine uptake. J. Med. Chem. 1991, 34, 702-705.
46. Kline, R. H., Jr. The synthesis and pharmacolgical activity of 3β-arylecgonine methyl ester and 3β-carbamoyIoxyecgonine methyl ester analogs: Probes for the characterization of the dopaminergic cocaine receptor; Ph.D. Thesis, University of Maryland at Baltimore, Baltimore, 1991.
47. Davies, H. M. L.; Saikai, E.; Sexton, T., Childers, S. R. Novel 2-substituted cocaine analogs: Binding properties at dopamine transport sites in rat striatum. Eur. J. Pharmacol., Mol. Pharmacol. Section. 1993, 244, 93-97.
48. Carroll, F. L; Mascarella, S. W.; Kuzemko, M. A.; Gao, Y.; Abraham, P.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J. Synthesis, ligand binding, and QSAR (CoMFA and classical) study of 3β(3′-substituted phenyl)-, 3β-(4′-substituted phenyl)-, and 3β-(3′4′disubstituted phenyl) tropane-2β-carboxylic acid methyl esters. J. Med. Chem. 1994, 37, 2865-2873.
49. Srivastava, S.; Cripen, G. M. Analysis of cocaine receptor site ligand binding by three-dimensional Voronoi site modeling approach. J. Med. Chem. 1993, 36, 3572-3579.
50. Pettitt, B. M.; Karplus, M. Molecular Graphics and Drug Design; Elsevier Science Publishers: New York, 1986.
51. Yang, B.; Wright, J.; Eldefrawi, M. E.; Pou, S.; MacKerell, A. D., Jr. Conformational, aqueous solvation, and pKa contributions to the binding and activity of cocaine, WIN 32 065-2, and the WIN vinyl analog. J. Am. Chem. Soc. 1994, 116, 8722-8732.
52. Karplus, M. Interpretation of the electron-spin resonance spectrum of the methyl radical. J. Phys. Chem. 1959, 30, 11-15.
53. Carroll, F. I.; Coleman, M. L.; Lewin, A. H. Synthesis and Conformational analysis of isomeric cocaines: A proton and carbon-13 nuclear magnetic resonance study. J. Org. Chem. 1982, 47, 13-19.
54. Kline, R. H. Jr.; Eshleman, A. J.; Wright, J.; Eldefrawi, M. E. Synthesis of substituted 3β-carbamoylecgonine methyl ester analogs: Irreversible and photoaffinity ligands for the cocaine receptor/dopamine transporter. J. Med. Chem. 1994,37, 22492252.'
55. Raymon, L. P.; Mahran, L. G.; Eldefrawi, M. E. The layer scintillation counting in drug-receptor binding. Anal. Lett. 1994, 27, 907-918.
56. Cramer, C. J.; Truhlar, D. G. An SCF solvation model for the hydrophobia effect and absolute free energies of aqueous solvation. Science 1992, 256, 213-217.
57. Cramer, C. J.; Truhlar, D. G. AM2-SM2 and PM3-SM3 parameterized SCF solvation models for free energies in aqueous solution. J. Comput.-Aided Mol. Des. 1992, 6, 629-666.
58. Dewar, M.; Zoebisch, E.; Healy, E.; Stewart, J. AMI: A new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 1985, 107, 3902-3909.
59. Cramer, C. J.; Truhlar, D. G. Molecular orbital theory calculations of aqueous solvation effects on chemical equilibria. J. Am. Chem. Soc. 1991, 113, 8552-8555.
60. Yang, B. Structure-activity relationship of cocaine analogs: synthesis of 3β-substituted analogs and computer-aided prediction of the pharmacological activity of cocaine analogs; Ph.D. Thesis, University of Maryland at Baltimore, Baltimore, 1994.
61. Gramer, R. D. Ill; Patterson, D. E.; Bunce, J. D. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of seriods to carrier proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
62. MacKerell, A. D., Jr.; Hemsen, A.; Lacroix, J. S.; Lundberg, J. M. Analysis of structure-function relationships of neuropeptide Y using molecular dynamics simulations and pharmacolgical activity and binding measurements. Reg. Pept. 1989,25, 295313
63. Brusniak, M. Y. K; Pearlman, R. S.; Neve, K. M.; Wilcox, R. E. Comparative molecular field analysis-based prediction of drug affinities at recombinant DIA dopamine receptors. J. Med. Chem. 1996, 39, 850-859.
64. Lowry, O. H.; Rosenbrough, N. J.; Fair, A. L.; Randall, R. L. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
65. Mine, R. H., Jr.; Wright, J.; Fox, K. M.; Eldefrawi, M. E. Synthesis of 3-arylecgonine analogues as inhibitors of cocaine binding and dopamine uptake. J. Med. Chem. 1990, 33, 20242027.
66. Milius, R. A.; Saha, J. K.; Madras, B. K.; Neumeyer, J. L. Synthesis and receptor binding of N-substituted tropane derivatives. High-affinity ligands for the cocaine receptor. J. Med. Chem. 1991, 34, 1728-1731.